Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

Thromb Haemost. 2010 Sep;104(3):650-2. doi: 10.1160/TH10-01-0022. Epub 2010 Jun 29.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Chi-Square Distribution
  • Factor XII / genetics*
  • Factor XIII / genetics*
  • Female
  • Genotype
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Myocardial Infarction / blood
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / genetics*
  • Odds Ratio
  • Phenotype
  • Polymorphism, Genetic*
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Spain
  • Thrombolytic Therapy*
  • Treatment Outcome

Substances

  • Factor XII
  • Factor XIII